Jon Cuthbert

Kezar Life Sciences (NASDAQ:KZR) announced Friday that the FDA has granted a formal Type C meeting for the first quarter of 2026, a move that could revive the clinical path for its lead asset, zetomipzomib, following months of regulatory uncertainty.

Appian Corp. (NASDAQ:APPN) announced it will pursue a second trial in its long-running trade secrets battle against Pegasystems (NASDAQ:PEGA0, following a Virginia Supreme Court ruling that refused to dismiss the case but sent it back to a lower court for a fresh look.

Zelensky says Ukraine has yet to receive firm security guarantees from allies amid ongoing peace discussions with Russia.

Optimism is considering funding OP token buybacks with Superchain fees to better align the asset’s value with network growth.

A Polymarket user who profited heavily from a Maduro ouster bet has disappeared from the platform.

Researchers have created salt-sized autonomous robots capable of sensing, swimming and operating independently for months.

Google has launched a major Gmail update using Gemini 3 to turn the inbox into an AI-powered assistant.

Polygon is said to be close to buying early bitcoin ATM provider Coinme in a deal valued at up to $125 million.

Vitura Health (ASX:VIT) has appointed finance executive Andrew Cook as its CFO. Based in Queensland, Cook is expected to assume the role in the third quarter of FY26.

WA1 Resources (ASX:WA1) announced further high-grade drilling results and project updates from its 100% owned Luni Niobium Project in Western Australia.